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Abstract
Objective: The primary objective was to estimate the burden of invasive pneumococcal disease (IPD) in children aged 1
month to 12 years in South Asian countries.
Methods: We searched three electronic databases (PubMed, Embase and the Cochrane Library) using a comprehensive
search strategy, we manually searched published databases (Index Medicus and Current Contents) and we also searched the
bibliographies of the included studies and retrieved reviews. The searches were current through June 2013. Eligible studies
(community-based and hospital-based) were pooled and a separate analysis for India was also completed. A meta-
regression analysis and heterogeneity analysis were performed. The protocol was registered with PROSPERO registration
number CRD42013004483.
Results: A total of 22 studies surveying 36,714 children were included in the systematic review. Hospital-based prospective
studies from South Asia showed that 3.57% of children had IPD, and 15% of all bacterial pneumonia cases were due to
Streptococcus pneumoniae. Indian studies showed that the incidence of IPD was 10.58% in children admitted to hospitals
with suspected invasive bacterial diseases, and 24% of all bacterial pneumonia cases were due to S. pneumonia. Population-
based studies from South Asian countries showed that 12.8% of confirmed invasive bacterial diseases were caused by S.
pneumonia whereas retrospective hospital-based studies showed that 28% of invasive bacterial diseases were due to S.
pneumoniae. Meta-regression showed that there was a significant influence of the antigen testing method for diagnosing
IPD on IPD prevalence.
Conclusion: S. pneumoniae is responsible for a substantial bacterial disease burden in children of South Asian countries
including India despite the presence of high heterogeneity in this meta-analysis. Treatment guidelines must be formulated,
and preventive measures like vaccines must also be considered.
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Introduction
Worldwide, pneumonia is the leading infectious cause of
mortality in children under five years of age [1]. Besides
pneumonia, meningitis and sepsis are also amongst the top killers
of children in the world [1]. World Health Organization (WHO)
estimates have shown that more than 90% of all deaths due to
pneumonia in children under the age of five occur in 40 countries.
The most deaths caused by pneumonia occur in India, with
Pakistan, Bangladesh and Afghanistan following close behind [2].
Morris et al. predicted that the mortality rates of children under
five years of age attributable to pneumonia are similar in Sub-
Saharan Africa and South Asia [3].
According to estimates, more than half of the new cases of
clinical pneumonia are concentrated in five countries, three of
which are in South Asia, i.e., India, Bangladesh and Pakistan [4].
This core of South Asian countries has a high incidence of clinical
pneumonia, with India having the highest number of new cases
detected worldwide. The mortality rates for children under five
years of age in the South Asian region ranges from 17/1000 for Sri
Lanka to 149/1000 for Afghanistan. Pneumonia claims the lives of
11% of children under the age of five in India, the Maldives,
Bangladesh and Pakistan, 23% in Afghanistan, 19% in Bhutan
and 6% in Sri Lanka [5].
Modern evidence on the aetiology of pneumonia is based on
two types of studies. The first type is hospital-based prospective
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studies, which rely on culture methods, and the second type is
vaccine trials, which measure the reduction in the burden of a
disease by specific vaccines against the disease [6,7]. Both types of
studies have found Streptococcus pneumoniae to be the leading cause of
pneumonia. S. pneumoniae is an encapsulated diplococcus with over
90 known capsular serotypes. It causes a wide spectrum of diseases
ranging from fatal invasive diseases like pneumonia, meningitis
and sepsis to noninvasive diseases like otitis media and sinusitis [8].
S. pneumoniae affects both extremes of age, i.e., children and the
elderly. South Asian countries have the highest incidence of
mortality due to invasive pneumococcal disease (IPD) [8].
Moreover, S. pneumoniae infections are the leading vaccine
preventable causes of mortality in children under the age of five
worldwide [8].
Although vaccines against S. pneumoniae are available in South
Asian countries, the majority have not included them in their
respective immunization schedules. This omission is due to the
paucity of data available on the burden of pneumococcal diseases
and the lack of information on the prevalent S. pneumoniae serotypes
in this region. Hence, this systematic review was conducted to
provide these data.
Objectives
The primary objective of this systematic review is to determine
the pneumococcal disease burden in children aged 1 month to 12
years in South Asian countries. These data can help policymakers
make decisions regarding the need for including pneumococcal
vaccines in national immunization schedules.
Methods
Inclusion Criteria
1. 1 Published Studies: prospective or retrospective studies that
included children aged 1 month to 12 years from South Asian
countries.
2. 2 Isolation of S. pneumoniae from included subjects.
3. 3 Minimum 12 months of surveillance.
Two authors decided upon the inclusion of studies, and others
performed quality assessment. Discrepancies, if any, were resolved
by discussion.
If the required data were not available, we contacted the
authors and attempted to retrieve the missing data. Studies that
commented only on pneumococcal serotypes and/or antibiotic
Figure 1. Flow diagram of search results.
doi:10.1371/journal.pone.0096282.g001
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resistance were excluded from the pooled analysis. We excluded
case reports, editorials, vaccine studies, literature reviews and
studies in which nasopharyngeal aspirates, throat swabs or
oropharyngeal swabs were the only samples used to determine
the causative organism.
Literature Search
We performed a systematic search of the published literature
and also tried to acquire unpublished data from various
investigators of the region. The searches were current as of June
2013. We identified articles with information on IPD amongst
children aged 1 month to 12 years. We searched three databases:
Medline via Ovid and PubMed, Embase and The Cochrane
Library. The reference lists of the obtained articles were further
searched for additional studies. Published databases (Index
Medicus and Current Contents) were also manually searched.
Non-English articles were not included. The search details are
given in Appendix S1. Searching was performed independently by
two authors.
General Definitions
South Asia includes Afghanistan, Pakistan, India, Nepal,
Bhutan, Bangladesh, Sri Lanka and the Maldives.
Burden of pneumococcal disease: We defined the burden
of pneumococcal disease as the number of positive pneumococcal
isolates from the suspected population (children aged 1 month to
12 years).
Hospital Based Surveillance Studies are those, which
involve monitoring a disease at a single facility or small number of
facilities.
Population Based Surveillance Studies are those, which
involve identifying all new cases of the disease under surveillance
in a defined population.
Disease Definitions
1 Pneumonia [9]
Symptoms: cough or difficult breathing. Signs: respiratory rate
.50 breaths per minute for infants aged two months to less than
one year, respiratory rate .40 breaths per minute for children
aged one to five years, and no chest indrawing, stridor or danger
signs.
2 Severe pneumonia [9]
Symptoms: cough or difficult breathing plus any general danger
sign, chest indrawing or stridor in a calm child. General danger
signs for children aged two months to five years include the
inability to drink or breastfeed, vomiting, convulsions and lethargy
or loss of consciousness.
3 Meningitis [9]
N Suspected: Any person with sudden onset of fever and one
of the following signs: neck stiffness, altered consciousness or
other meningeal sign.
N Probable: A suspected case with cerebrospinal fluid (CSF)
examination showing at least one of the following:
N turbid appearance;
N leukocytosis (.100 cells/mm3);
N leukocytosis (10–100 cells/mm3) and either elevated
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N Confirmed: A case that is laboratory-confirmed by
growing (i.e., culturing) or identifying (i.e., using antigen
detection methods) a bacterial pathogen (pneumococcus) in
the CSF or blood of a child with a clinical syndrome
consistent with bacterial meningitis.
4 Nonpneumonia nonmeningitis
All infections other than pneumonia and meningitis were
categorized under this heading.
5 Invasive pneumococcal disease
When pneumococcus is identified from one of the otherwise
sterile sites of the body, such as blood, CSF or pleural fluid, either
by culture, the latex agglutination test (LAT), polymerase chain
reaction (PCR) or another technique.
Data Collection and Management
Four authors independently abstracted data from the included
studies in a predesigned pro forma that included study design,
setting, number of suspected cases, site for sample collection,
number of samples collected for culture, number of cultures
positive for pneumococcus and prior use of antibiotic. The data
from hospital-based and population-based studies were abstracted
separately. Authors were contacted to obtain missing data. To
resolve discrepancies regarding the abstracted data, a consensus
was drawn by discussion with the other reviewers. If discrepancies
were not resolved, the data were not included in the pooled
analysis.
Data Analysis
Data analysis was performed using STATA-MP 12, two-core,
which is manufactured by Stata Corp., Ltd. Similar data from the
studies were pooled for analysis. We calculated the proportion of
pneumococcus isolated from the total bacterial isolates of the study
population. The proportion of invasive pneumococcal disease
from total suspected population was calculated using the total
number of children with suspected invasive disease in the study as
the denominator and for calculating the proportion of invasive
pneumococcal disease from invasive bacterial disease the denom-
inator used was the number of children with positive bacterial
isolates either by culture or antigen testing. Additional analysis was
performed to calculate the incidence of IPD in South Asian
children less than 5 years of age and in Indian children aged 1
month to 12 years. Subgroup analysis was performed for
pneumonia and meningitis. Data from hospital-based prospective
studies, hospital-based retrospective studies and community-based
studies were analysed separately. We calculated I2, Tau2 and the Z
test for heterogeneity amongst the studies, and the Galbraith plot
was used to represent the heterogeneity. To analyse publication
bias, Begg’s test, Kendall’s score, Egger’s linear regression and the
funnel plot were used.
Results
Data Reviewed
We found 713 published articles through electronic and manual
searches. After screening the titles and abstracts, 42 full-text
articles were retrieved, of which 22 studies fulfilled the inclusion
criteria and were included in the analysis (Figure 1, Table 1) [10–
31]. Twenty studies were excluded from the systematic review
[32–51], as shown in Table 2. The total number of children
Table 2. Characteristics of excluded studies.
S. no Study name Comments
1. Patwari et al, 1988 [46] No available data on causative organism
2. Mastro et al 1991 [41] Antibiotic resistance only
3. Mastro et al,1993 [42] Study period is ,1 year, Nasopharyngeal aspirates only
4. Awasthi et al 1997 [35] No data on S. pneumoniae
5. Saha et al 1997 [48] Serotype details only
6. Saha et al 1999 [49] Mentions about antibiotic resistance only
7. Jebaraj et al 1999 [40] Nasopharyngeal colonization study
8. Addo-Yobo et al 2004 [50] Randomized controlled trial, has mixed data of Asia and Africa and South America also
9. Acharya et al 2003 [32] Does not report for S. pneumoniae
10. Mehta et al,2003 [44] Tells about Antibiotic resistance only does not give the details of S. pneumoniae and other causative organism
11. Bansal et al, 2006 [36] Not reported S. pneumoniae so cannot be included
12. Bharti et al, 2006 [38] No information on S. pneumoniae
13. Hussain et al 2006 [39] Cost of treatment study
14. Nizami et al 2006 [45] Oropharyngeal aspirate only
15. SPEAR study 2008 [34] Study does tell only about India but has included other regions which are not a part of South Asia, Randomized Control Trial
16. Agarwal et al, 2009 [33] Short report; No data for S. pneumoniae
17. Saha et al 2009 [51] Serotype details only
18. Rijal et al 2010 [47] Serotype details only
19. Mathisen et al 2010 [43] Study on viruses
20. Bansal et al, 2004 [37] Study of adults
doi:10.1371/journal.pone.0096282.t002
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surveyed was 36,714. Of these subjects, 2,539 children were
confirmed to have a bacterial disease. A total of 663 children less
than 12 years of age were confirmed to have IPD. A detailed
analysis of each study type was completed separately and is
described below.
Hospital-based Prospective Studies
South Asian Countries: (children aged 1 month to 12
years). We identified sixteen hospital-based prospective studies
from various South Asian countries [10–17,21,23–26,28,30,31],
and the pooled analysis using the random effects model showed
that 3.57% (95% CI 2.66–4.49) of children admitted to hospitals
with suspected invasive bacterial diseases were due to S. pneumoniae.
Nine studies showed that only 1.4% (95% CI 0.68–2.12) of
children admitted with severe pneumonia were due to pneumo-
coccus (Figure 2) [11,13,14,16,23–26,31]. Ten studies found that
in 8.86% (95% CI 5.68–12.4) of children with probable or
confirmed meningitis, S. pneumoniae was the causative organism
(Figure 2) [10,12,14,15,17,21,23,25,26,28]. Of the positive bacte-
rial isolates from cases of invasive bacterial diseases, 23.74% (95%
CI 17.47–30.01) were identified as S. pneumoniae by culture, LAT or
PCR. Isolates from patients with severe pneumonia and pyogenic
Figure 2. Forest plot showing the proportion of IPD from hospital-based prospective studies on South Asian children aged 1 month
to 12 years with suspected invasive bacterial disease. The plot also shows the subgroup analysis for the pneumococcal pneumonia cases
among all of the pneumonia patients and for the pneumococcal meningitis cases among all of the meningitis patients.
doi:10.1371/journal.pone.0096282.g002
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meningitis showed that 15.07% (95% CI 8.69–21.45) and 34.23%
(95% CI 22.45–46.01) were due to S. pneumonia, respectively
(Figure 3). Pneumococcus contributed insignificantly to all causes
of pneumonia, but was still one of the leading causes of bacterial
pneumonia as demonstrated by the meta-analysis.
South Asian Countries (Children ,5 years of age). Of the
16 studies included, only 12 studies [11,13,15,16,21,23–
26,28,30,31] published data on children less than 5 years of age.
The meta-analysis showed that 2.98% (95% CI 2.08–3.89%) of
children less than 5 years of age who were hospitalized with
suspected invasive bacterial disease had S. pneumoniae infections. In
South Asian children less than 5 years of age, the rate of
pneumococcal pneumoniae was 1.37% (95% CI 0.58–2.17%) and
the rate of pneumonia and pneumococcal meningitis of all causes
was 9.08% (95% CI 4.09–14.07%) (Figure 4). In this age group,
pneumococcus caused approximately 24% of all confirmed,
invasive, bacterial diseases (Figure 5). Pneumococcal pneumonia
was responsible for 14.87% (95% CI 8.54–21.20%) of all cases of
bacterial pneumonia, and pneumococcal meningitis was respon-
sible for 36.81% (95% CI 20.76–52.87%) of all cases of pyogenic
meningitis (Figure 5).
Hospital-based Studies (India). Ten Indian studies [10–
17,21,31] showed that S. pneumoniae causes 10.58% (95% CI 6.87–
14.28) of invasive diseases, 7.62% (95% CI 3.6–11.64) of severe
pneumonia cases, and 11.21% (95% CI 5.88–16.54) of meningitis
cases in children with suspected bacterial diseases aged 1 month to
Figure 3. Forest plot showing the proportion of IPD from hospital-based prospective studies in South Asian children aged 1 month
to 12 years with confirmed invasive bacterial disease. The plot also shows a subgroup analysis for the pneumococcal pneumonia cases
among all of the bacterial pneumonia patients and for the pneumococcal meningitis cases among all of the pyogenic meningitis patients.
doi:10.1371/journal.pone.0096282.g003
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12 years (Figure 6). Streptococcus was a major bacterium isolated
from severe pneumonia and pyogenic meningitis cases. S.
pneumoniae was confirmed in 24.3% (95% CI 7.06–41.61) of
bacterial isolates from pneumonia cases and in 32.78% (95% CI
20.44–45.12) of pyogenic meningitis cases (Figure 7).
Population-based Studies
Four population-based, active surveillance studies from South
Asian countries were included in the review [18,19,22,29]. These
studies were conducted in Pakistan and Bangladesh and only
examined children less than 5 years of age. These studies showed
that S. pneumoniae was present in 12.88% (95% CI 4.02–21.73) of
all positive bacterial isolates (Figure 8).
Hospital-based Retrospective Studies
Two hospital-based retrospective studies from India were
included in this review [20,27]. The pooled data showed that S.
pneumoniae was present in 28.36% (95% CI 22.74–79.46) of isolates
from the total number of admitted patients with invasive bacterial
diseases.
Meta-regression Analysis
Table 3 shows the results of the final model in which age (,5
years versus any age up to 12 years), setting (hospital versus
community), diagnostic method (culture versus culture + LAT),
study centre (multicentre versus single site) and organ system
(clinical sepsis versus specific organ system) were estimated as
random effects parameters. Associations between prevalence rates
and predictors were assessed using the multivariate method
Figure 4. Forest plot showing the proportion of IPD from hospital-based prospective studies in South Asian children under the age
of 5 with suspected invasive bacterial disease. The plot also shows a subgroup analysis for the pneumococcal pneumonia cases among all of
the pneumonia patients and for the pneumococcal meningitis cases among all of the meningitis patients.
doi:10.1371/journal.pone.0096282.g004
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including the predictors that were found to be significant in the
univariate meta-regression. The odds of IPD were increased by
9% in studies using culture as well as LAT as diagnostic modalities
when compared to studies using culture testing alone, and this
association showed a trend toward significance (OR 1.09; 95% CI:
0.99–1.21). Similarly, the IPD prevalence was significantly
lowered by 10% in studies where all suspected IPD cases involving
any body organ were enrolled in comparison to studies where only
subjects with pneumonia or meningitis (i.e., single organ involve-
ment) were investigated (OR 0.90; 95% CI: 0.81–0.99) (Table 3)
Publication Bias
We used Begg’s test to identify any publication bias in the
review. A significant P-value of 0.003 in the above output of
Kendall’s tau by Begg’s test indicates the presence of publication
bias in this meta-analysis. However, Egger’s linear regression test
showed a nonsignificant coefficient (2.63) of publication bias (95%
CI: 23.62 to 8.88) (P-value 0.39). We also used the funnel plot
(Figure 9) to identify publication bias. The funnel plot was
asymmetric and indicated that there were missing studies. Using
the trim and fill method in our meta-analysis, it was shown that 10
studies were missing. Under the random-effects model, the point
estimate and 95% CI for the pooled prevalence of the combined
studies was 2% (1.5–2.5%), which was reduced to 0.09% (0.03–
1.5%) using the trim and fill method (Figure 10).
Heterogeneity
For each trial, the z statistic (effect size/standard error [SE] of
effect size) was plotted against the reciprocal SE (1/SE) of the
effect size. The unweighted regression line was constrained
Figure 5. Forest plot showing the proportion of IPD from hospital-based prospective studies in South Asian children less than 5
years of age with confirmed invasive bacterial disease. The plot also shows a subgroup analysis for the pneumococcal pneumonia cases
among all the bacterial pneumonia patients and for the pneumococcal meningitis cases among all of the pyogenic meningitis patients.
doi:10.1371/journal.pone.0096282.g005
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through the origin with its 95% CI, and it showed a slope equal to
the overall pooled prevalence estimate in the fixed effects meta-
analysis.
The position of each trial on the horizontal axis gives an
indication of the weight allocated to it in the meta-analysis. The
position on the vertical axis represents the contribution of each
trial to the Q statistic for heterogeneity (Figure 11). The results of
the I2 analysis and Tau2 analysis are shown in Table 4.
Discussion
The meta-analysis showed that only 1.4% of all severe
pneumonia cases in South Asia were due to pneumococcus,
which contrasts with the results of other reviews. However, when
we examined the bacterial isolates, pneumococcus had a
significant contribution in severe pneumonia patients, and it is
clearly a major bacterium responsible for severe pneumonia and
meningitis. Although several other pathogens including viruses
were detected, pneumococcus is an important pathogen that
causes severe pneumonia and requires hospitalization.
In India, pneumococcus is a frequent cause of invasive bacterial
diseases. It is a common bacterium isolated from children with
severe bacterial pneumonia and children with pyogenic meningi-
tis. This meta-analysis demonstrates that IPDs are more common
in India than in other South Asian countries.
Although the results come from surveillance studies, which are
not generally considered good quality evidence, the studies
included in this review were characterized by quality, and they
were based on a pretested questionnaire and were rated
accordingly. Most of the hospital-based studies were from tertiary
care centres where sick and referred patients are admitted, and
overestimates are expected. Prior antibiotic use is also common in
these patients, which alters the results. In this review, 12 studies
reported prior antibiotic usage in 18% of children. This high rate
of antibiotic use must have affected the isolation of the causative
Figure 6. Forest plot showing the proportion of IPD from hospital-based prospective studies in Indian children aged 1 month to 12
years with suspected invasive bacterial disease. The plot also shows a subgroup analysis for the pneumococcal pneumonia cases among all of
the pneumonia patients and for the pneumococcal meningitis cases among all of the meningitis patients.
doi:10.1371/journal.pone.0096282.g006
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Figure 7. Forest plot showing the proportion of IPD from hospital-based prospective studies in Indian children aged 1 month to 12
years with confirmed invasive bacterial disease. The plot also shows a subgroup analysis for the pneumococcal pneumonia cases among all of
the bacterial pneumonia patients and for the pneumococcal meningitis cases among all of the pyogenic meningitis patients
doi:10.1371/journal.pone.0096282.g007
Figure 8. Forest plot showing the proportion of IPD from population-based prospective studies in South Asian children aged 1
month to 12 years with suspected invasive bacterial disease.
doi:10.1371/journal.pone.0096282.g008
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bacteria. Only the population-based studies from Bangladesh and
Pakistan matched the inclusion criteria. Thus, the lack of
population-based studies from other countries weakens this
meta-analysis. The heterogeneity, due to the different sample
sizes, age groups and syndromes investigated in the individual
studies, was significant as estimated by the I2 and Tau2 tests, and
thus, a random effects model was used [52].
This is the first systematic review of IPDs in South Asia. The
meta-analysis showed that S. pneumoniae was the most common
bacterium isolated. Though there was a difference in the figures
obtained from hospital- and community-based studies, both types
of studies reported a high number of cases with S. pneumoniae
infections.
O’ Brien et al. performed a global estimation of the IPD
burden and found that India had the highest mortality due to
IPD [8]. Rudan et al. showed that India had the highest number
of new cases diagnosed worldwide [4]. Johnson et al. tried to
determine the most prevalent pneumococcal serotypes globally
and found that serotype 14 was the most common cause of IPD
in every region, and serotype 1 was common in Asia [53]. Our
findings suggest that pneumococcus is the bacterium most
commonly isolated by culture, LAT or PCR in fluids from
otherwise sterile sites, which suggests that it is the most common
aetiologic agent responsible for invasive bacterial diseases in the
region. The previous research confirms the same findings using
different methods. We analysed the observed frequency of S.
pneumoniae through a meta-regression framework. In this respect,
we accounted for the influence of various covariates on the
observed prevalence of S. pneumoniae, such as age, diagnostic test
used, surveillance setting, study centre and organ system
involved.
The results show that pneumococcus poses a significant burden
on the healthcare system and also affects the economic condition
of patient’s family. Steps should be taken to counter this
organism, which could involve preventive measures by immuniz-
ing against S. pneumonia with vaccines like PCV-7, PCV-13 and
PCV-10 and also by providing a clean and hygienic environment.
Additionally, these steps could involve providing easily approach-
able healthcare facilities, low-cost antibiotics and home-based
follow-ups. Preventive steps should be the first approach. Pakistan
is the only country from South Asia to realize the importance of
prevention by introducing PCV-10 into its immunization
schedule with the help of the GAVI alliance. Bangladesh will
also introduce the vaccine shortly. Because India forms the largest
part of South Asia and as the data suggests it also forms the
largest pneumococcal hub, preventive steps should be initiated in
India soon. Most of the Indian data is based on nasopharyngeal
sampling, which does not describe the aetiologic role of S.
pneumoniae but only provides information about its carriage. As
described by Johnson et al. [53], PCV-10 or PCV-13 could
prevent 80% of all pneumococcal diseases, and a relevant
vaccine should be introduced after determining the prevalent
serotypes.
Furthermore, increasing drug resistance is creating another
problem. Studies from South Asia have shown that there is
increasing drug resistance to available antibiotics. In the
IndiaCLEN Short Course Amoxycillin Therapy for Pneumonia
(ISCAP) trial, the resistance pattern of S. pneumoniae to various
antibiotics was: cotrimoxazole 66.3%, chloramphenicol 9.0%,
oxacillin 15.9% and erythromycin 2.8% [54]. The Asian
Network for Surveillance of Resistant Pathogens (ANSORP)
study reported that 41% of strains were not susceptible to
penicillin in Sri Lanka, and this rate was approximately 4% in
India [55]. Kunango et al. reported that out of 150 clinical
isolates from invasive pneumococcal infections, only 11 (7.3%)
isolates were relatively resistant to penicillin, although 64 were
resistant to one or more antibiotics, especially cotrimoxazole,
tetracycline and chloramphenicol [56]. Unpublished data from
one site of a multicentric trial IndiaCLEN severe pneumonia oral
therapy (ISPOT) study in India showed that in approximately
38% of children with severe radiologically-confirmed pneumonia,
S. pneumoniae was isolated from the nasopharyngeal aspirates or
throat swabs. The study also showed that oral amoxicillin
administered at home was effective in treating severe pneumonia.
Table 3. Univariate and multivariate meta-regression of IPD prevalence.
Odds ratio# 95% CI# P value# Odds ratio* 95% CI* P value*
Age (,5 years vs. any age upto 12 years) 0.93 0.82–1.06 0.271
Surveillance setting (Hospital versus community), 1.10 0.96–1.26 0.139
Diagnostic testing method(Culture versus culture + LAT) 1.11 0.99–1.24 0.066 1.09 0.99–1.21 0.083
Study centre(Multicentric versus single site) 0.97 0.86–1.10 0.630
Organ system(Any clinical sepsis versus specific organ system
alone)
0.89 0.80–0.99 0.036 0.9 0.81–0.99 0.046
#for univariate meta-regression; *for multivariate meta-regression.
doi:10.1371/journal.pone.0096282.t003
Figure 9. Funnel plot showing the publication bias.
doi:10.1371/journal.pone.0096282.g009
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The No Shots study from Pakistan concluded that home
treatment with high-dose oral amoxicillin in cases of severe
pneumonia is equivalent to WHO recommendations [57].
Similarly, another study from Pakistan showed that local health
workers were able to treat severe pneumonia cases at home with
high-dose amoxicillin [58]. Moreover, Das and Singh showed
that oral amoxicillin administered either in a hospital or in a
community setting was effective in treating severe pneumonia and
was not inferior to the standard treatment [59].
The authors strongly feel that there is a need for the
introduction of a pneumococcal conjugate vaccine in South Asian
countries. The prevalent serotypes should first be determined in
order to introduce a relevant vaccine. Drug resistance should be
assessed, and treatment guidelines should then be revisited in view
of increasing drug resistance.
Figure 10. Corrected funnel plot using the trim and fill method.
doi:10.1371/journal.pone.0096282.g010
Figure 11. Galbraith plot showing heterogeneity.
doi:10.1371/journal.pone.0096282.g011
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